ACTRN12607000404426
Not yet recruiting
Phase 2
A study to evaluate the effectiveness of Posterior Capsule Stretches on increasing range, decreasing pain and increasing function in people with Subacromial Impingement Syndrome (SAIS)
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- Subacromial Impingement Syndrome
- Sponsor
- Queensland Health
- Enrollment
- 60
- Status
- Not yet recruiting
- Last Updated
- 6 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Patients with a clinical diagnosis of unilateral SAIS and at least four weeks duration of symptoms. The diagnosis will be based on the patients' history and a clinical examination, which will include the reproduction of pain with shoulder internal rotation at ninety degrees of flexion (Hawkins Test) and posterior shoulder tightness as indicated by a loss of more than 2 cm on crossed adduction shoulder measures when compared to the unaffected side (Tyler et al., 1999\). All genders included.
Exclusion Criteria
- •Patients will be excluded from the study if they have a history or current diagnosis of dislocation with an associated positive apprehension test, rotator cuff tears/rupture, adhesive capsulitis, acromioclavicular joint pathology, cervical spine pathology, neurological pathology, systemic disease affecting the upper limb (e.g. cancer or rheumatological disease), heart failure, radiological/imaging findings of internal derangement of the glenohumeral joint, bilateral upper limb pain, trauma to the upper limb within the previous four weeks, or physiotherapy treatment for this condition within the last six month (Desmeules et al., 2003\).
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, not recruiting
Phase 1
An Evaluation of Efficacy and Safety of Posterior Juxtascleral Administrations of Anecortave Acetate for Depot Suspension (15 mg or 30 mg) versus Sham Administration in Patients (Enrolled in Study A” or Study B”) at Risk for Developing Sight-Threatening Choroidal Neovascularisation (CNV) Due to Exudative Age-Related Macular Degeneration (AMD). - Anecortave Acetate Risk Reduction Trial (AART)non-exudative age related macular degeneration (dry AMD)EUCTR2005-001598-93-ESAlcon Research Limited2,500
Active, not recruiting
Not Applicable
An Evaluation of Efficacy and Safety of Posterior Juxtascleral Administrations of Anecortave Acetate for Depot Suspension (15 mg or 30 mg) versus Sham Administration in Patients (Enrolled in Study A” or Study B”) at Risk for Developing Sight-Threatening Choroidal Neovascularisation (CNV) Due to Exudative Age-Related Macular Degeneration (AMD) - Anecortave Acetate Risk Reduction Trial (AART)non-exudative age related macular degeneration (dry AMD)EUCTR2005-001598-93-DKAlcon Research Limited2,500
Completed
Not Applicable
The clarification of influence that dialogue through support system give for clinical symptoms of dementia patient with hearing loss.dementiaJPRN-UMIN000037415Institute of Biomedical Sciences, Tokushima University Graduate School7
Recruiting
Not Applicable
A prospective study for evaluation of efficacy of a 12mm diameter polytetrafluoroethylene partial covered stent in malignant extrahepatic biliary obstructioKCT0005989Asan Medical Center161
Completed
Phase 2
A prospectve study to evaluate the efficacy of pregabalin for chemotherapy-induced peripheral nueralgiaPatients who suffers from peripehral neuralgia which is induced by antineaoplastic agents that were adeministered for therapy of hematological malignanciesJPRN-UMIN000005647Tokyo University, Dep. of Hematology and Oncology50